Tuesday, March 31, 2026

One-Mouth, Two-Words Policy: Top Experts Expose Lee’s Failure To Follow His Own North Korea Plan

Concerns arise over the Lee Jae-myung administration's END Initiative, suggesting it may mislead North Korea regarding regime change.

New Breakthrough: HER2 Positive Stomach Cancer Treatment with Dual Targeted Therapy Shows 81% Tumor Size Reduction

A study reveals that combining trastuzumab deruxtecan and pertuzumab significantly reduces tumor size in HER2-positive gastric cancer.

UN Condemns North Korea: 20 Years of Human Rights Resolutions

The United Nations General Assembly adopted a resolution condemning North Korea's systematic and widespread human rights violations.

Tag: cholangiocarcinoma

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review

HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.